Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Worldwide Pharmacogenomics (PGX) Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026

  • PRO4481204
  • 124 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Due to the high popularity of this product/service in North America and Asia, the growth trend of Pharmacogenomics (PGX) in recent years and the growth of consumers' demand is expected to drive the global Pharmacogenomics (PGX) market.

Geographically, the global Pharmacogenomics (PGX) market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.

North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Pharmacogenomics (PGX) market in North America.

Significant participants active in the global Pharmacogenomics (PGX) market include: Pathway Genomics, GeneDx., Affymetrix, Inc., 23andMe, Inc., GE Healthcare, Abbott Laboratories, OSI Pharmaceuticals, GeneTech, Transgenomic, Inc., Genset, Pfizer, Inc., Thermo Fisher Scientific, Myriad Genetics, Inc., Illumina, Inc....

Global Pharmacogenomics (PGX) Market Segmentation:

Pharmacogenomics (PGX) market, by Pharmacogenomics (PGX) type:

Microarray

Sequencing

Polymerase Chain Reaction

Others

…

Pharmacogenomics (PGX) market, by Application:

Oncology

Cardiology

Neurological Disorders

Others

…

Pharmacogenomics (PGX) Market Research Report 2014-2026, by region:

North America

The U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Latin America

Mexico

Brazil

Argentina

Pan Asia Pacific

China

Japan

South Korea

South East Asia Region

India

Australia

Middle East and Africa

Saudi Arabia

UAE

Qatar

Egypt

Nigeria

South Africa

Rest of MEA

The database is running updated by a group of research experts to always reflect the latest trends and information.

Table of Content

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Volume Units

1.8 Review Cycle

1.9 Summary and Key Findings of the Research

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach (Involves time, Space, and Persons)

2.3 Data Triangulation

2.4 Assumptions

2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research

2.6 Limitations of Our Study

2.7 Scene Based Modeling

2.8 Covid-19 Impact/Evaluation

3. Market Dynamics

3.1 Driving Factors

3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

3.1.2 Increasing Use of Pharmacogenomics (PGX) by Different End-User/Applications

3.2 Restraints and Challenges in the Market

3.3 Opportunities

4. Global Pharmacogenomics (PGX) Market-Segmentation

4.1 By Type

4.1.1 Microarray

4.1.2 Sequencing

4.1.3 Polymerase Chain Reaction

4.1.4 Others

4.2 By End-User/Application Industry

4.2.1 Oncology

4.2.2 Cardiology

4.2.3 Neurological Disorders

4.2.4 Others

4.3 By Geography

4.3.1 North America Pharmacogenomics (PGX) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.1.1 North America Pharmacogenomics (PGX) Production from 2014-2020

4.3.1.2 North America Pharmacogenomics (PGX) Consumption from 2014-2020

4.3.1.3 North America Pharmacogenomics (PGX) Import and Export from 2014-2020

4.3.1.4 North America Pharmacogenomics (PGX) Market Value ($) and Growth (%) by Type from 2019-2020

4.3.1.5 North America Pharmacogenomics (PGX) Market Value ($) and Growth (%) by Application from 2019-2020

4.3.1.6 North America Pharmacogenomics (PGX) Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.1.7 Top North America Pharmacogenomics (PGX) Participants Value ($) and Market Share (%) in 2019

4.3.2 Europe Pharmacogenomics (PGX) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.2.1 Europe Pharmacogenomics (PGX) Production from 2014-2020

4.3.2.2 Europe Pharmacogenomics (PGX) Consumption from 2014-2020

4.3.2.3 Europe Pharmacogenomics (PGX) Import and Export from 2014-2020

4.3.2.4 Europe Pharmacogenomics (PGX) Market Value ($) and Growth (%) by Type from 2019-2020

4.3.2.5 Europe Pharmacogenomics (PGX) Value ($) and Growth (%) by Application from 2019-2020

4.3.2.6 Europe Pharmacogenomics (PGX) Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.2.7 Top Europe Pharmacogenomics (PGX) Participants Value ($) and Market Share (%) in 2019

4.3.3 Asia-Pacific Pharmacogenomics (PGX) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.3.1 Asia-Pacific Pharmacogenomics (PGX) Production from 2014-2020

4.3.3.2 Asia-Pacific Pharmacogenomics (PGX) Consumption from 2014-2020

4.3.3.3 Asia-Pacific Pharmacogenomics (PGX) Import and Export from 2014-2020

4.3.3.4 Asia-Pacific Pharmacogenomics (PGX) Value ($) and Growth (%) by Type from 2019-2020

4.3.3.5 Asia-Pacific Pharmacogenomics (PGX) Value ($) and Growth (%) by Application from 2019-2020

4.3.3.6 Asia-Pacific Pharmacogenomics (PGX) Value ($) and Growth (%) by Countries from 2019-2020

4.3.3.7 Top Asia-Pacific Pharmacogenomics (PGX) Participants Value ($) and Market Share (%) in 2019

4.3.4 Latin America Pharmacogenomics (PGX) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.4.1 Latin America Pharmacogenomics (PGX) Production from 2014-2020

4.3.4.2 Latin America Pharmacogenomics (PGX) Consumption from 2014-2020

4.3.4.3 Latin America Pharmacogenomics (PGX) Import and Export from 2014-2020

4.3.4.4 Latin America Pharmacogenomics (PGX) Value ($) and Growth (%) by Type from 2019-2020

4.3.4.5 Latin America Pharmacogenomics (PGX) Value ($) and Growth (%) by Application from 2019-2020

4.3.4.6 Latin America Pharmacogenomics (PGX) Value ($) and Growth (%) by Countries from 2019-2020

4.3.4.7 Top Latin America Pharmacogenomics (PGX) Participants Value ($) and Market Share (%) in 2019

4.3.5 Middle East & Africa Pharmacogenomics (PGX) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.5.1 Middle East & Africa Pharmacogenomics (PGX) Production from 2014-2020

4.3.5.2 Middle East & Africa Pharmacogenomics (PGX) Consumption from 2014-2020

4.3.5.3 Middle East & Africa Pharmacogenomics (PGX) Import and Export from 2014-2020

4.3.5.4 Middle East & Africa Pharmacogenomics (PGX) Value ($) and Growth (%) by Type from 2019-2020

4.3.5.5 Middle East & Africa Pharmacogenomics (PGX) Value ($) and Growth (%) by Application from 2019-2020

4.3.5.6 Middle East & Africa Pharmacogenomics (PGX) Value ($) and Growth (%) by Countries from 2019-2020

4.3.5.7 Top Middle East & Africa Pharmacogenomics (PGX) Participants Value ($) and Market Share (%) in 2019

5. Competitive Intelligence – Company Profiles

5.1 Pathway Genomics

5.1.1 Pathway Genomics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.1.2 Pathway Genomics Sales, Growth Rate and Global Market Share from 2014-2020

5.2 GeneDx.

5.2.1 GeneDx. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.2.2 GeneDx. Sales, Growth Rate and Global Market Share from 2014-2020

5.3 Affymetrix, Inc.

5.3.1 Affymetrix, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.3.2 Affymetrix, Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.4 23andMe, Inc.

5.4.1 23andMe, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.4.2 23andMe, Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.5 GE Healthcare

5.5.1 GE Healthcare Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.5.2 GE Healthcare Sales, Growth Rate and Global Market Share from 2014-2020

5.6 Abbott Laboratories

5.6.1 Abbott Laboratories Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.6.2 Abbott Laboratories Sales, Growth Rate and Global Market Share from 2014-2020

5.7 OSI Pharmaceuticals

5.7.1 OSI Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.7.2 OSI Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2020

5.8 GeneTech

5.8.1 GeneTech Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.8.2 GeneTech Sales, Growth Rate and Global Market Share from 2014-2020

5.9 Transgenomic, Inc.

5.9.1 Transgenomic, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.9.2 Transgenomic, Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.10 Genset

5.10.1 Genset Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.10.2 Genset Sales, Growth Rate and Global Market Share from 2014-2020

5.11 Pfizer, Inc.

5.11.1 Pfizer, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.11.2 Pfizer, Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.12 Thermo Fisher Scientific

5.12.1 Thermo Fisher Scientific Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.12.2 Thermo Fisher Scientific Sales, Growth Rate and Global Market Share from 2014-2020

5.13 Myriad Genetics, Inc.

5.13.1 Myriad Genetics, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.13.2 Myriad Genetics, Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.14 Illumina, Inc.

5.14.1 Illumina, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.14.2 Illumina, Inc. Sales, Growth Rate and Global Market Share from 2014-2020

6. Investment Analysis

6.1 Fundamental Analysis (Porter's Five Forces Analysis)

6.2 Technical Preparation Analysis

6.3 Risk Evaluating Analysis

6.4 Estimated Investment Pay-Back Period

7. Future Forecast of the Global Pharmacogenomics (PGX) Market from 2021-2026

7.1 Future Forecast of Global Pharmacogenomics (PGX) Market from 2021-2026 Segment by Region

7.2 Future Forecast of the Global Pharmacogenomics (PGX) Market from 2021-2026 Segment by Types

7.3 Future Forecast of the Global Pharmacogenomics (PGX) Market from 2021-2026 Segment by End-User/Applications

8 Appendix

8.1 Discussion Guide

8.2 Related Reports

8.3 Author List

9 Disclaimer

List of Tables and Figures

Global Pharmacogenomics (PGX) Market Value ($) and Growth Rate of Pharmacogenomics (PGX) from 2014-2026

Global Pharmacogenomics (PGX) Production and Growth Rate Segment by Product Types from 2014-2026F

Global Pharmacogenomics (PGX) Consumption and Growth Rate Segment by End-User/Application from 2014-2026E

Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Table Global Pharmacogenomics (PGX) Production and Growth Rate Segment by Product Types from 2014-2020

Table Global Pharmacogenomics (PGX) Value ($) and Growth Rate Segment by Product Types from 2014-2020

Figure Microarray of Pharmacogenomics (PGX)

Figure Sequencing of Pharmacogenomics (PGX)

Figure Polymerase Chain Reaction of Pharmacogenomics (PGX)

Figure Others of Pharmacogenomics (PGX)

Table Global Pharmacogenomics (PGX) Consumption and Growth Rate Segment by End-User/Application from 2014-2020

Table Global Pharmacogenomics (PGX) Value ($) and Growth Rate Segment by End-User/Application from 2014-2020

Figure Oncology of Pharmacogenomics (PGX)

Figure Cardiology of Pharmacogenomics (PGX)

Figure Neurological Disorders of Pharmacogenomics (PGX)

Figure Others of Pharmacogenomics (PGX)

Table Global Pharmacogenomics (PGX) Production Value ($) by Regions

Table Global Pharmacogenomics (PGX) Production Value Share by Regions

Table Global Pharmacogenomics (PGX) Production by Regions

Table Global Pharmacogenomics (PGX) Production Share by Regions

Table Global Pharmacogenomics (PGX) Consumption by Regions

Table Global Pharmacogenomics (PGX) Consumption Share by Regions

Figure North America Pharmacogenomics (PGX) Production and Growth Rate from 2014-2020

Figure North America Pharmacogenomics (PGX) Consumption and Growth Rate from 2014-2020

Table North America Pharmacogenomics (PGX) Import and Export from 2014-2020

Table North America Pharmacogenomics (PGX) Value ($) and Growth (%) by Type from 2019-2020

Table North America Pharmacogenomics (PGX) Value ($) and Growth (%) by Application from 2019-2020

Table North America Pharmacogenomics (PGX) Value ($) and Growth (%) by Countries from 2019-2020

Table Top North America Pharmacogenomics (PGX) Participants Value ($) and Market Share (%) in 2019

Figure Europe Pharmacogenomics (PGX) Production and Growth Rate from 2014-2020

Figure Europe Pharmacogenomics (PGX) Consumption and Growth Rate from 2014-2020

Table Europe Pharmacogenomics (PGX) Import and Export from 2014-2020

Table Europe Pharmacogenomics (PGX) Value ($) and Growth (%) by Type from 2019-2020

Table Europe Pharmacogenomics (PGX) Value ($) and Growth (%) by Application from 2019-2020

Table Europe Pharmacogenomics (PGX) Market Value ($) and Growth (%) by Countries from 2019-2020

Table Top Europe Pharmacogenomics (PGX) Participants Value ($) and Market Share (%) in 2019

Figure Asia-Pacific Pharmacogenomics (PGX) Production and Growth Rate from 2014-2020

Figure Asia-Pacific Pharmacogenomics (PGX) Consumption and Growth Rate from 2014-2020

Table Asia-Pacific Pharmacogenomics (PGX) Import and Export from 2014-2020

Table Asia-Pacific Pharmacogenomics (PGX) Value ($) and Growth (%) by Type from 2019-2020

Table Asia-Pacific Pharmacogenomics (PGX) Value ($) and Growth (%) by Application from 2019-2020

Table Asia-Pacific Pharmacogenomics (PGX) Value ($) and Growth (%) by Countries from 2019-2020

Table Top Asia-Pacific Pharmacogenomics (PGX) Participants Value ($) and Market Share (%) in 2019

Figure Latin America Pharmacogenomics (PGX) Production and Growth Rate from 2014-2020

Figure Latin America Pharmacogenomics (PGX) Consumption and Growth Rate from 2014-2020

Table Latin America Pharmacogenomics (PGX) Import and Export from 2014-2020

Table Latin America Pharmacogenomics (PGX) Value ($) and Growth (%) by Type from 2019-2020

Table Latin America Pharmacogenomics (PGX) Value ($) and Growth (%) by Application from 2019-2020

Table Latin America Pharmacogenomics (PGX) Value ($) and Growth (%) by Countries from 2019-2020

Table Top Latin America Pharmacogenomics (PGX) Participants Value ($) and Market Share (%) in 2019

Figure Middle East & Africa Pharmacogenomics (PGX) Production and Growth Rate from 2014-2020

Figure Middle East & Africa Pharmacogenomics (PGX) Consumption and Growth Rate from 2014-2020

Table Middle East & Africa Pharmacogenomics (PGX) Import and Export from 2014-2020

Table Middle East & Africa Pharmacogenomics (PGX) Value ($) and Growth (%) by Type from 2019-2020

Table Middle East & Africa Pharmacogenomics (PGX) Value ($) and Growth (%) by Application from 2019-2020

Table Middle East & Africa Pharmacogenomics (PGX) Value ($) and Growth (%) by Countries from 2019-2020

Table Top Middle East & Africa Pharmacogenomics (PGX) Participants Value ($) and Market Share (%) in 2019

Table Pathway Genomics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Pathway Genomics Sales and Growth Rate from 2014-2020

Figure Pathway Genomics Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table GeneDx. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure GeneDx. Sales and Growth Rate from 2014-2020

Figure GeneDx. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Affymetrix, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Affymetrix, Inc. Sales and Growth Rate from 2014-2020

Figure Affymetrix, Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table 23andMe, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure 23andMe, Inc. Sales and Growth Rate from 2014-2020

Figure 23andMe, Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table GE Healthcare Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure GE Healthcare Sales and Growth Rate from 2014-2020

Figure GE Healthcare Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Abbott Laboratories Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Abbott Laboratories Sales and Growth Rate from 2014-2020

Figure Abbott Laboratories Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table OSI Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure OSI Pharmaceuticals Sales and Growth Rate from 2014-2020

Figure OSI Pharmaceuticals Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table GeneTech Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure GeneTech Sales and Growth Rate from 2014-2020

Figure GeneTech Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Transgenomic, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Transgenomic, Inc. Sales and Growth Rate from 2014-2020

Figure Transgenomic, Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Genset Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Genset Sales and Growth Rate from 2014-2020

Figure Genset Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Pfizer, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Pfizer, Inc. Sales and Growth Rate from 2014-2020

Figure Pfizer, Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Thermo Fisher Scientific Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Thermo Fisher Scientific Sales and Growth Rate from 2014-2020

Figure Thermo Fisher Scientific Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Myriad Genetics, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Myriad Genetics, Inc. Sales and Growth Rate from 2014-2020

Figure Myriad Genetics, Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Illumina, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Illumina, Inc. Sales and Growth Rate from 2014-2020

Figure Illumina, Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Global Pharmacogenomics (PGX) Value ($) and Growth Rate Forecast by Regions (2021-2026)

Table Global Pharmacogenomics (PGX) Production and Growth Rate Forecast by Regions (2021-2026)

Table Global Pharmacogenomics (PGX) Consumption and Growth Rate Forecast by Regions (2021-2026)

Table Global Pharmacogenomics (PGX) Production and Growth Rate Forecast by Types (2021-2026)

Table Global Pharmacogenomics (PGX) Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390